The global Biopsy devices market size was estimated to be around US$ 2.29 billion in 2023 and is projected to reach US$ 4.29 billion by 2032, indicating a CAGR of 7.20% from 2023 to 2032.
Key Takeaways
- North America region contributed more than 34% of revenue share in 2022.
- Asia-Pacific is estimated to expand the fastest CAGR between 2023 and 2032.
- By product, the needle-based biopsy guns segment held the largest market share of 36% in 2022.
- By product, the biopsy needles segment is anticipated to grow at a remarkable CAGR of 8.6% between 2023 and 2032.
- By end use, the hospitals segment generated over 46% of revenue share in 2022.
- By end use, the clinics segment is expected to expand at the fastest CAGR over the projected period.
The Biopsy Devices Market is a dynamic and crucial segment within the healthcare industry, playing a pivotal role in the diagnosis and treatment of various medical conditions. Biopsy devices are instrumental in obtaining tissue samples for laboratory analysis, aiding in the identification of diseases such as cancer and other pathological conditions. This market encompasses a diverse range of devices, including needles, forceps, guidance systems, and imaging devices, each designed to enhance precision and efficiency in the biopsy process.
Get a Sample: https://www.precedenceresearch.com/sample/3612
Growth Factors
- Technological Advancements: The continuous evolution of biopsy device technologies has significantly contributed to the market’s growth. Advanced imaging techniques, real-time guidance systems, and minimally invasive biopsy procedures have improved accuracy, reduced patient discomfort, and expanded the scope of applications.
- Rising Incidence of Cancer: With the global surge in cancer cases, the demand for biopsy devices has witnessed a substantial increase. These devices are essential for early and accurate cancer diagnosis, enabling timely initiation of treatment. As cancer prevalence continues to rise, the biopsy devices market is expected to experience sustained growth.
- Increasing Geriatric Population: The demographic shift towards an aging population has led to a higher incidence of age-related diseases, including cancer. Biopsy procedures are frequently required in elderly patients, driving the demand for innovative and less invasive devices to ensure optimal diagnostic outcomes with minimal patient impact.
- Growing Awareness and Screening Programs: Public awareness campaigns and organized screening programs for various diseases, particularly cancer, have contributed to an increased demand for biopsy procedures. As more individuals participate in routine screenings, the biopsy devices market is poised for expansion to meet the diagnostic needs of a proactive healthcare consumer base.
- Global Healthcare Infrastructure Development: Investments in healthcare infrastructure across the globe have facilitated improved access to advanced medical procedures, including biopsies. Developing regions witnessing an upgrade in their healthcare facilities are likely to be significant contributors to the market’s growth.
Biopsy Devices Market Scope
| Report Coverage | Details |
| Growth Rate from 2023 to 2032 | CAGR of 7.20% |
| Market Size in 2023 | USD 2.29 Billion |
| Market Size by 2032 | USD 4.29 Billion |
| Largest Market | North America |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Application and By End Use |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Read More: X-Ray Detectors Market Size To Rise USD 5.81 Billion By 2032
By Application
In the dynamic landscape of the Biopsy Devices Market, diverse applications drive the demand for these essential medical tools. Cancer diagnosis remains a prominent application, with biopsy devices playing a crucial role in obtaining tissue samples for accurate identification and assessment of malignancies. The precision and efficiency of these devices contribute significantly to early detection and subsequent treatment planning, enhancing the overall prognosis for patients.
By End Use
The Biopsy Devices Market caters to a spectrum of end users, reflecting the widespread utility of these devices across the healthcare industry. Hospitals emerge as major consumers, relying on biopsy tools for diagnostic and therapeutic procedures. Ambulatory surgical centers also play a pivotal role, leveraging these devices to facilitate minimally invasive procedures with reduced patient discomfort. The accessibility and adaptability of biopsy devices make them indispensable for various end users, fostering advancements in medical practices and patient care.
Reasons to Purchase this Report:
- Comprehensive market segmentation analysis incorporating qualitative and quantitative research, considering the impact of economic and policy factors.
- In-depth regional and country-level analysis, examining the demand and supply dynamics that influence market growth.
- Market size in USD million and volume in million units provided for each segment and sub-segment.
- Detailed competitive landscape, including market share of major players, recent projects, and strategies implemented over the past five years.
- Comprehensive company profiles encompassing product offerings, key financial information, recent developments, SWOT analysis, and employed strategies by major market players.
Biopsy Devices Market Players
- Medtronic plc
- Becton, Dickinson, and Company
- Hologic, Inc.
- Boston Scientific Corporation
- Olympus Corporation
- C. R. Bard, Inc. (acquired by BD)
- Cook Medical LLC
- FUJIFILM Holdings Corporation
- Mauna Kea Technologies
- Devicor Medical Products, Inc.
- Leica Biosystems Nussloch GmbH (Danaher Corporation)
- INRAD Inc.
- Argon Medical Devices, Inc. (acquired by Shandong Weigao Group Medical Polymer Company Limited)
- Scion Medical Technologies LLC
- MDxHealth SA
Segments Covered in the Report
By Application
- Needle-based Biopsy Guns
- Biopsy Guidance Systems
- Biopsy Forceps
- Biopsy Needles
By End Use
- Hospitals
- Clinics
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Biopsy Devices Market
5.1. COVID-19 Landscape: Biopsy Devices Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Biopsy Devices Market, By Application
8.1. Biopsy Devices Market Revenue and Volume, by Application, 2023-2032
8.1.1. Needle-based Biopsy Guns
8.1.1.1. Market Revenue and Volume Forecast (2020-2032)
8.1.2. Biopsy Guidance Systems
8.1.2.1. Market Revenue and Volume Forecast (2020-2032)
8.1.3. Biopsy Forceps
8.1.3.1. Market Revenue and Volume Forecast (2020-2032)
8.1.4. Biopsy Needles
8.1.4.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 9. Global Biopsy Devices Market, By End Use
9.1. Biopsy Devices Market Revenue and Volume, by End Use, 2023-2032
9.1.1. Hospitals
9.1.1.1. Market Revenue and Volume Forecast (2020-2032)
9.1.2. Clinics
9.1.2.1. Market Revenue and Volume Forecast (2020-2032)
9.1.3. Others
9.1.3.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 10. Global Biopsy Devices Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.1.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
10.1.3. U.S.
10.1.3.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.1.3.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.1.4.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
10.2. Europe
10.2.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.2.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
10.2.3. UK
10.2.3.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.2.3.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
10.2.4. Germany
10.2.4.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.2.4.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
10.2.5. France
10.2.5.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.2.5.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.2.6.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
10.3. APAC
10.3.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.3.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
10.3.3. India
10.3.3.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.3.3.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
10.3.4. China
10.3.4.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.3.4.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
10.3.5. Japan
10.3.5.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.3.5.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.3.6.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
10.4. MEA
10.4.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.4.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
10.4.3. GCC
10.4.3.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.4.3.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
10.4.4. North Africa
10.4.4.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.4.4.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
10.4.5. South Africa
10.4.5.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.4.5.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.4.6.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
10.5. Latin America
10.5.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.5.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
10.5.3. Brazil
10.5.3.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.5.3.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Volume Forecast, by Application (2020-2032)
10.5.4.2. Market Revenue and Volume Forecast, by End Use (2020-2032)
Chapter 11. Company Profiles
11.1. Medtronic plc
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Becton, Dickinson, and Company
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Hologic, Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Boston Scientific Corporation
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Olympus Corporation
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. C. R. Bard, Inc. (acquired by BD)
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Cook Medical LLC
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. FUJIFILM Holdings Corporation
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Mauna Kea Technologies
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Devicor Medical Products, Inc.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.expresswebwire.com/
Blog: https://www.uswebwire.com/
Blog: https://www.dailytechbulletin.com/
Blog: https://www.autoindustrybulletin.com/
